The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Robichaud Albert since year 2005.
The trader's CIK number is 1612861.
At the time of this reporting, Robichaud Albert is the Chief Scientific Officer of Sage Therapeutics, Inc. .
(stock ticker symbol SAGE).
See this page for all insider trading activities at Sage Therapeutics, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2017-12-14||SAGE||Sage Therapeutics, Inc.||Sale||60,000||159.86||9,591,600|
|2016-10-28||SAGE||Sage Therapeutics, Inc.||Option Ex||15,287||1.36||20,790|
|2016-07-12||SAGE||Sage Therapeutics, Inc.||Sale||22,000||40.00||880,000|
|2016-01-25||SAGE||Sage Therapeutics, Inc.||Sale||20,000||40.02||800,400|
|2015-08-03||SAGE||Sage Therapeutics, Inc.||Sale||12,000||67.06||804,720|
|2015-07-01||SAGE||Sage Therapeutics, Inc.||Sale||16,000||71.61||1,145,808|
|2015-06-01||SAGE||Sage Therapeutics, Inc.||Sale||16,000||72.43||1,158,816|
|2014-07-23||SAGE||Sage Therapeutics, Inc.||Buy||4,000||18.00||72,000|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Robichaud Albert (Chief Scientific Officer of Sage Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.